Answers are grounded in this paper and cite their sources.
Multiple pharmacological options exist for treating insomnia in LTC residents, including Z-drugs, DORAs, and doxepin. The choice of treatment should consider efficacy, safety, patient characteristics, and the need for personalized care, with an emphasis on minimizing risks.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: